Types Of Signal In Pharmacovigilance
Pharmacovigilance is concerned with detecting the possible risks associated with a drug or treatment. Risks are monitored and assessed throughout ...Read more >
News
What’s the difference between Phase 2 and Phase 3 Clinical Trials?
In previous years, pharmacology and clinical trials were topics which mainly interested medical professionals, rather than the public. However, as ...Read more >
What is Clinical Pharmacology and Therapeutics?
Clinical pharmacology and therapeutics is the science of medicines and how they are used to diagnose, prevent and treat diseases ...Read more >
Rare Diseases: Everything you need to know
In the UK alone, it’s estimated that around 3 million people are living with a rare disease or condition. The ...Read more >
Pulmonary Deposition of BUD/Glycopyrrolate/Formoterol in COPD Patients
A scintigraphy study of budesonide/ glycopyrrolate/ formoterol fumarate metered dose inhaler in patients with moderate‑to‑very severe chronic obstructive pulmonary disease. ...Read more >
Fundraising for Findacure for Rare Disease Day 2021
As a CRO specialising in clinical trials for rare and orphan diseases, Rare Disease Day has become a special cause ...Read more >
Read our latest article - Rare disease clinical trials continue, thanks to new technology
Rare Disease Day offers a valuable opportunity to raise awareness of rare disease and campaign for health equity. We are ...Read more >
Simbec-Orion Streamlines Trial Execution With Veeva Clinical Applications
Vault CTMS and Vault eTMF provide complete visibility into trials, enabling CRO to deliver value-added services to sponsors PLEASANTON, Calif.–(BUSINESS WIRE)–Veeva ...Read more >
Simbec-Orion and Oncodistinct Network agreement to strengthen early phase oncology research
Providing oncology drug developers with the successful delivery of early phase oncology studies. Slough, Berkshire, United Kingdom: Simbec-Orion announced a ...Read more >
Exvastat wins a 3.6 million euro grant for COVID-19 trial
Congratulations to Cambridge Innovation Capital portfolio company Exvastat that has been awarded a grant from the prestigious Innovative Medicines Initiative. ...Read more >
Maintaining an agile and collaborative approach during the COVID-19 Pandemic
Simbec-Orion COVID-19 Update 1 April 2020
Lending a Hand to Support Rare Disease Day
As a CRO focusing on rare disease, we are delighted to support EURODIS’s 12th international Rare Disease Day. Taking inspiration from ...Read more >